文献速递慢阻肺哮喘

基于大型数据库的α1-抗胰蛋白酶缺乏症诊断患病率及其合并症分析

The prevalence of diagnosed α1-antitrypsin deficiency and its comorbidities: results from a large population-based database.
PubMed 文献 · Eur Respir J · 2017-01-04

AATD患者合并非AATD哮喘或肺气肿患者更常见的高血压、慢性肾脏病和糖尿病,且较非AATD慢阻肺患者就诊和住院更频繁、更长久。

要点

  • AATD诊断患病率全年龄段为23.73/10万,≥30岁为29.36/10万。
  • AATD患者高血压、慢性肾脏病和糖尿病患病率高于非AATD哮喘或肺气肿患者。
  • AATD患者较非AATD慢阻肺患者就诊次数更多,住院更频繁且更长久。

核心结论

  • AATD与多种其他疾病相关,且AATD患者的医疗资源利用高于非AATD阻塞性肺疾病患者。

主要发现

  • 共识别673例AATD患者(其中590例≥30岁),全年龄段患病率23.73/10万,≥30岁患病率29.36/10万。
  • 基于样本中检出673例(总样本2 836 585人),外推德国研究期间有19 162例AATD患者。
  • AATD患者高血压、慢性肾脏病和糖尿病患病率高于非AATD哮喘或肺气肿患者。
  • 与非AATD慢阻肺患者相比,AATD患者就诊次数显著更多,住院更频繁且时间更长。

临床怎么用

  • 在呼吸科临床中,对慢阻肺、肺气肿或哮喘患者应考虑AATD诊断,尤其关注合并高血压、慢性肾脏病和糖尿病的患者。
  • AATD患者可能需要更密集的随访和医疗资源规划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

α1-Antitrypsin deficiency (AATD) is a genetically determined disorder that is associated with different clinical manifestations. We aimed to assess the prevalence of diagnosed AATD and its comorbidities using a large healthcare database.In this retrospective longitudinal observational study, we analysed data from 4 million insurants. Using International Classification of Diseases revision 10 (ICD-10) codes, we assessed the prevalence, comorbidities and healthcare utilisation of AATD patients (E88.0 repeatedly coded) relative to non-AATD patients with chronic obstructive pulmonary disease (COPD), emphysema or asthma.In our study population, we identified 673 AATD patients (590 aged ≥30 years), corresponding to a prevalence of 23.73 per 100 000 in all age groups and 29.36 per 100 000 in those ≥30 years. Based on the number of AATD cases detected in the sample size (673 out of 2 836 585), we extrapolated that there were 19 162 AATD cases in Germany during the years studied. AATD patients had a higher prevalence of arterial hypertension, chronic kidney disease and diabetes relative to non-AATD asthma or emphysema patients. When compared to non-AATD COPD patients, AATD patients had significantly more consultations and more frequent and longer hospitalisations.Our data strengthen the assumption that AATD is associated with a variety of other diseases. Healthcare utilisation appears to be higher among AATD patients as compared to patients with non-AATD-related obstructive lung diseases.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Greulich T, Nell C, Hohmann D, et al. The prevalence of diagnosed α1-antitrypsin deficiency and its comorbidities: results from a large population-based database. Eur Respir J. 2017. PMID: 27824593. doi:10.1183/13993003.00154-2016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。